Skip to content
value.today
Guerbet SA logo

Guerbet SA

GBT.PA
$268 Mlast known market cap, Jan 2024 — no current value
Compare
World rank
—
no current market cap
Revenue
$887 M
For year ending December-2025
Net income
$-122 M
-13.8% margin
Official annual report (ESEF)
Employees
—

Guerbet SA in brief

Guerbet SA is a listed company in the Medical Devices industry, based in France. Its last known market value was $268 M (January 2024); there is no current figure. In the year to December 2025 it had sales of $887 M and a net loss of $122 M. Its shares trade under the symbol GBT.PA (EURONEXT).

Written from the figures on this page, so it changes when they do. Dates and sources are under Sources and freshness.

Guerbet SA timeline

2 events, 1967–2014
  1. 1967
  2. 🏁
    · approximate
    Incorporated as Guerbet
  3. 2014
  4. •
    Legal Entity Identifier issued
    LEI 969500WV1U1WQ059L135 registered.

Events of Guerbet SA from the GLEIF LEI register. Dates marked approximate come from statements without a cited source. Spotted a mistake? Use the correction form below.

Market cap history

$0 M$162 M$323 M$485 M$647 M20202021202220232024

World rank over time

▼ down 6,292 places since 2020
2020-01-01: #10092#10,09220202021-01-01: #11124#11,12420212022-01-07: #13231#13,23120222022-12-25: #17490#17,49020222023-07-30: #15816#15,81620232024-01-05: #16384#16,3842024

Rank in France: #189 (Jan 2020) · #202 (Jan 2021) · #210 (Jan 2022) · #244 (Dec 2022) · #227 (Jul 2023) · #220 (Jan 2024)

Key ratios

market cap and latest results
P/E ratio
n/m (loss)
Price / sales
—
Price / book
—
Free cash flow yield
—
Net margin
-13.8%
Operating margin
-11.2%
Return on equity
-40.0%
Liabilities / assets
72.0%
Revenue growth
-2.6%

Financial history

USD · fiscal years · source: official annual reports (ESEF)
RevenueNet income
Fiscal year ending Dec 2024: revenue $910M, net income $17M$910MFY24Fiscal year ending Dec 2025: revenue $887M, net income $-122M$887MFY25
Fiscal year endingRevenueGrowthOperating incomeNet incomeNet margin
Dec 2025$887M-2.6%$-99M$-122M-13.8%
Dec 2024$910M—$54M$17M1.9%

Cash flow, debt and per share

Fiscal year endingOperating cash flowCapital spendingFree cash flowEPS (diluted)Dividend / share
Dec 2025$91M$34M$58M$-10.05—
Dec 2024$88M$35M$53M$1.16—

Annual results

Revenue
$887 M
Operating income
$-99 M
Net income
$-122 M

For year ending December-2025 · source: official annual report (ESEF)

Balance sheet

Total assets
$1.1 B
Total liabilities
$787 M
Total equity
$306 M

As of December-2025

Mutual funds holding Guerbet SA#

13 funds hold shares worth $0 M. Since their previous reports 1 added shares and 7 sold, selling $0 M net.
Mutual funds holding Guerbet SA
FundSharesValueOf the companyOf the fundChange in sharesReport
🇺🇸 International Core Equity 2 PortfolioDimensional Fund Advisors LP13,657$0 M—<0.01%no changeJul 31, 2026
🇺🇸 Dimensional International Small Cap Value ETFDimensional Fund Advisors LP9,744$0 M—<0.01%no changeJul 31, 2026
🇺🇸 Dfa International Small Cap Value PortfolioDimensional Fund Advisors LP9,141$0 M—<0.01%−49%Jul 31, 2026
🇺🇸 The Continental Small Company SeriesDimensional Fund Advisors LP6,930$0 M—<0.01%−71%Jul 31, 2026
🇺🇸 Dimensional International Core Equity 2 ETFDimensional Fund Advisors LP5,225$0 M—<0.01%no changeJul 31, 2026
🇺🇸 Dimensional VA International Small PortfolioDimensional Fund Advisors LP1,370$0 M—<0.01%no changeJul 31, 2026
🇺🇸 LVIP Dimensional International Core Equity FundLincoln Financial Investments Corporation783$0 M—<0.01%no changeJun 30, 2026
🇺🇸 World ex U.S. Core Equity PortfolioDimensional Fund Advisors LP663$0 M—<0.01%−71%Jul 31, 2026
🇺🇸 Avantis International Equity ETFAmerican Century ETF Trust463$0 M—<0.01%no changeMay 31, 2026
🇺🇸 AZL DFA International Core Equity FundAllianz Investment Management LLC405$0 M—<0.01%no changeJun 30, 2026
🇺🇸 International Small Company TrustJohn Hancock Variable Trust Advisers LLC326$0 M—<0.01%no changeJun 30, 2026
🇺🇸 Avantis Responsible International Equity ETFAmerican Century ETF Trust100$0 M—<0.01%+1.0%May 31, 2026
🇺🇸 Avantis International Small Cap Value FundAmerican Century ETF Trust63$0 M—<0.01%no changeMay 31, 2026

Source: Fund portfolio reports to the SEC (Form N-PORT), CVM, Finansinspektionen and Indian fund houses · as of Jul 31, 2026. The 13 largest positions, each from the fund's newest report; report dates differ between funds. A fund family's funds are listed one by one, so one manager can appear many times.

Ownership and subsidiaries

Source: GLEIF
Guerbet SA directly owns 3 registered entities in 3 countries:

Guerbet SA scorecard#

Passes 0 of the 5 checks that could be worked out. Fiscal year 2025.

  • Valuationnot known
    • –P/E below its peers' medianNo market cap.
    • –Price to book below its peers' medianNo market cap.
    • –Price to sales below its peers' medianNo market cap.
    • –Free cash flow yield above 5%No market cap.
    • –Earnings yield above the 10-year Treasury yieldNo market cap.
    • –The price assumes slower growth than the last three years'No market cap.
  • Growth0 of 2
    • ✗Revenue grew in the newest year-2.6%Revenue down 2.6% in fiscal 2025.
    • –Revenue up more than 5% a year over three yearsRevenue of three years earlier is not on file.
    • –Faster growth over three years than its peers' medianRevenue of three years earlier is not on file.
    • ✗Earnings per share grew in the newest year-10.05 vs 1.16Diluted EPS -10.05 in fiscal 2025 against 1.16 the year before (report's currency).
    • –Net income higher than five years earlierNet income of five years earlier is not on file.
    • –Revenue rose in at least four of the last five yearsFive years of revenue changes are not on file.
  • Profitability0 of 3
    • ✗Profitable in the newest year-$122 MNet income -$122 M in fiscal 2025.
    • –Profitable in each of the last five yearsFive years of net income are not on file.
    • ✗Operating margin above its peers' median-11.2%-11.2% against Medical Devices's median of -8.2% (86 companies).
    • ✗Return on equity above 15%-34.3%-34.3% in fiscal 2025.
    • –Return on invested capital above 10%No return on invested capital on file.
    • –Operating margin wider than three years earlierOperating margins of three years earlier are not on file.
  • Financial healthnot known
    • –Short-term assets cover short-term liabilitiesCurrent assets and liabilities are not on file.
    • –Debt below equityDebt or equity is not on file (or equity is negative).
    • –Net debt below three years of EBITDANet debt to EBITDA is not on file.
    • –Operating income covers interest five timesInterest expense is not on file.
    • –Cash from operations positive in each of the last three yearsThree years of operating cash flow are not on file.
    • –Altman Z-score outside the distress zoneThe Z-score's figures are not all on file.
  • Shareholder returnsnot known
    • –Pays a dividendDividends are not on file.
    • –Dividend per share raised five years in a rowSix years of dividends per share are not on file.
    • –Dividends under 75% of net incomePays no dividend (or dividends are not on file).
    • –Share count up no more than 2% in a yearShare counts of two years are not on file.
    • –Dividends and buybacks above 3% of the market valueNo market cap.
    • –Free cash flow covers dividends and buybacksPaid out nothing in the newest year.

Worked out from the statements as filed (esef), the medians of Medical Devices, the 10-year Treasury yield of Nov 13, 2026 and the market cap (too old for the valuation checks, which need one at most 60 days old). A check that cannot be worked out counts neither way. A reading aid, not advice. How the checks work

Financial analysis, 2025#

Worked out from Guerbet SA's statements, beside the median of Medical Devices.

Guerbet SA: main financial ratios in 2025
Ratio2025Median of peers
Operating margin-11.2%-8.2%
Net margin-13.8%-10.4%
Return on equity-34.3%-16.8%
Revenue growth-2.6%10.4%
Free cash flow margin6.5%-1.9%

2of 5on the Piotroski tests of financial strength

  • Revenue fell 2.6% against the year before.
  • Net loss of $122 million.

Guerbet SA: financial statements#

Income statement, balance sheet and cash-flow statement as reported, newest period first.

Amounts in EUR millions; per-share figures in EUR; share counts in millions. Hover a figure for its filing and XBRL tag. Growth compares with the year before; shares are of revenue (income and cash flow) or of total assets (balance sheet).

Guerbet SA: statements by fiscal year
PeriodTrendFY 2025to Dec 31, 2025FY 2024to Dec 31, 2024FY 2023to Dec 31, 2023FY 2022to Dec 31, 2022FY 2021to Dec 31, 2021FY 2020to Dec 31, 2020
Income statement
Revenue786841786753732712
Operating income−885039−183942
Income tax3.15.98.613−3.74.0
Net income including minority interests−1131322−413318
Minority interests' share of net income−4.3−2.6−1.70——
Net income attributable to shareholders−1081624−413318
Earnings per share, basic-8.911.071.75-3.252.591.45
Earnings per share, diluted-8.911.071.75-3.252.581.44
Dividends per share—0.00—0.50——
Balance sheet
Cash and cash equivalents11650514211697
Inventory294301305272202205
Current assets601590582510495469
Property, plant and equipment215291294286274261
Other intangible assets————189188
Non-current assets329447444430505477
Total assets9301,0371,0259401,001946
Accounts payable8595931048164
Current liabilities241254229240237200
Non-current liabilities429391418320359378
Shareholders' equity267394378380405364
Minority interests−6.9−2.7−0.10——
Total equity260392378380405368
Total liabilities and equity9301,0371,0259401,001946
Cash-flow statement
Depreciation and amortization16273581235858
Share-based compensation−0.70.70.2−0.40.6−1.3
Cash from operating activities81812730116120
Capital expenditure−30−32−42−44−38−40
Intangible assets bought−6.7−25−12−6.7−11−20
Acquisitions, net of cash acquired——−2.70——
Cash from investing activities−34−53−60−55−52−57
Debt issued87134462.46.67.3
Debt repaid−47−14−384−36−34−41
Shares issued00000.60.1
Dividends paid0−6.3−6.3−11−8.8−8.8
Cash from financing activities20−2845−49−41−47
Exchange-rate effect on cash−2.4−1.4−2.7−0.60.1−3.7
Change in cash65−0.99.6−742313
ReportESEFESEFESEFESEFESEFESEF

Build a DCF model from these statements: revenue, margins, tax, depreciation, capital spending, working capital, debt, cash and shares filled in from the annual reports, every assumption yours.

Source: ESEF annual reports (filings.xbrl.org) · as of Dec 31, 2025. A fiscal year is listed under the calendar year it mostly falls in; quarters are numbered within the company's fiscal year. Balance-sheet figures are those at the end of each period. Payments in the cash-flow statement are negative

Where Guerbet SA operates: 3 countries#

Countries where the company has its headquarters, an office, subsidiaries, a branch or reported revenue. 3 subsidiaries on file.

Guerbet SA: countries of operation
CountryPresenceRevenue there
🇫🇷 FranceHeadquarters2 offices1 subsidiary—
🇧🇪 Belgium1 subsidiary—
🇮🇪 Ireland1 subsidiary—

Source: GLEIF legal-entity register, SEC Exhibit 21 and annual reports, office addresses on file. A country without subsidiaries or offices on record is not listed even if the company sells there. How presence is decided

How Guerbet SA compares in Medical Devices

  • Revenue$887 M · higher than 81% of 155
  • Net margin-13.8% · higher than 41% of 144
  • Revenue growth-2.6% · higher than 15% of 104

Peer comparison · Medical Devices

CompanyMarket capP/ENet marginRev. growth
Guerbet SA🇫🇷$268 M—-13.8%-2.6%
Abbott Laboratories🇺🇸$181.1 B38.5×9.8%+5.7%
Medtronic plc🇺🇸$121.2 B23.2×13.9%+8.4%
Stryker Corporation🇺🇸$116.5 B32.2×13.8%+11.2%
Boston Scientific Corporation🇺🇸$66.2 B18.9×16.6%+19.9%
Edwards Lifesciences Corporation🇺🇸$52.8 B51.7×15.3%+11.6%
Shenzhen Mindray Bio-Medical Electronics Co., Ltd.🇨🇳$27.8 B23.6×24.4%—
STERIS plc🇮🇪$20.4 B24.6×13.4%+8.7%
Zimmer Biomet Holdings, Inc.🇺🇸$18.2 B23.8×8.9%+7.2%

P/E and margins use trailing 12-month results where available; growth is the latest fiscal year.

Questions, comparisons and similar companies#

Sources and freshness

Market cap:
Jan 5, 2024 (last known)
Annual results:
For year ending December-2025
Balance sheet:
As of December-2025
Profile updated:
Nov 15, 2026

Figures from Official annual report (ESEF), value.today research, GLEIF register.

How each figure is collected: data sources and methodology. Market caps in US dollars unless you switch the currency.

Work at Guerbet SA? Verify and update this profile — free

Use your work e-mail address (on the company's own domain if possible). Fill in only what is new or missing; a link to where the figures are published (annual report, press release) speeds up the review.

Show Guerbet SA's ranking or a chart on your website Get the badge
Badge preview

The badge updates itself as the ranking changes.

Something wrong or missing about Guerbet SA? Suggest a correction